Joël Lemaoult

Title: Joël Lemaoult: Innovator in Cancer Prognosis and Monitoring

Introduction

Joël Lemaoult is a notable inventor based in Melun, France. He has made significant contributions to the field of cancer research, particularly in the prognosis and monitoring of bladder cancer. His innovative work has led to the development of methods that could potentially improve patient outcomes.

Latest Patents

Lemaoult holds a patent for "Methods for the monitoring and prognosis of a cancer." This invention focuses on measuring the proportion of CD8T Lymphocytes expressing ILT-2 and the plasma level of soluble HLA-G. Additionally, it includes the use of anti-HLA-G antibodies for treating cancers where tumor cells express HLA-G, with a specific emphasis on bladder cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Joël Lemaoult has worked with prominent organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Université Paris Diderot-Paris 7. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Lemaoult has collaborated with esteemed colleagues, including François Desgrandchamps and Edgardo Delfino Carosella. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Joël Lemaoult's contributions to cancer prognosis and monitoring exemplify the importance of innovation in medical research. His work has the potential to significantly enhance the understanding and treatment of bladder cancer.